This is an adapted excerpt from the Feb. 20 episode of “The Rachel Maddow Show.” For 26 years, the state of Missouri was represented in Congress by Republican Roy Blunt. He began as Rep. Blunt, serving in House Republican leadership for years, before becoming a senator. Blunt, among everything else he did during his time […]
Experts make recommendations for federal funding of research projects over the next 10 years Alzheimer’s disease affects nearly seven million Americans over the age of 65, or 1 in 9 people in this age group, according to the Alzheimer’s Association. Symptoms such as memory loss, trouble concentrating and performing familiar tasks, and personality changes start […]
Adam Steensberg, the chief executive of Danish biotech Zealand Pharma, which is developing an alternative weight loss product based on a different hormone, says “there is a duopoly already” in the GLP-1 market. Combining different drugs could be a way of expanding the effects of GLP-1s further still. Doctors such as Perkovic envisage a possible […]
Credit: K H Fung/Science Photo Library Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in September, some researchers have proclaimed a new era for psychiatric medicine. About half a dozen similar drugs — for schizophrenia, Alzheimer’s disease and other conditions involving the brain — are […]
Alzheimer’s disease is a progressive neurologic disorder that causes memory loss and other cognitive decline due to brain cell degeneration. It’s the most common cause of dementia — a clinical syndrome characterized by a collection of symptoms that affect cognitive abilities, memory, thinking behavior. Dementia is not a specific disease itself. It’s estimated that more […]
Cognitive tests would be used less often to diagnose Alzheimer’s disease under a proposal by some scientists.Credit: Burger/Phanie/Science Photo Library Controversy has erupted among researchers over an effort to adopt blood tests and brain scans for diagnosing Alzheimer’s disease, rather than the cognitive screening that has been used for decades. Proponents of the change say […]
Credit: Steve Russell/Toronto Star via Getty Colombian neurologist Francisco Lopera, who has died aged 73, changed the course of research on Alzheimer’s disease — both with insights into its mechanism and with his personal, family-centred, long-term approach. He met with thousands of people in a single family, parsing their stories to track hereditary dementia. This […]
Editor’s Note: September is World Alzheimer’s Month DEAR MAYO CLINIC: I am part of what I hear called the Sandwich Generation. I have kids living at home and an aging parent in ill health. My mom is 83 and in an assisted living facility with physical and cognitive problems. She has been diagnosed with mild […]
